Cannapharmarx, Inc. (CPMD)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.00
- As of
Kresmion compiles this page from CPMD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
CANNAPHARMARX, INC. (CPMD): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-18.
See the full CPMD dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CPMD on one page. Preview it with sample data, then open it live with a free account.
Preview the CPMD dossierActive events for CPMD
- mediumEarnings below estimates
Q4-1999: Missed consensus by 47.1% - EPS $-4.2 vs $-2.856 estimate
- mediumEarnings below estimates
Q1-2000: Missed consensus by 88.5% - EPS $-5 vs $-2.652 estimate
- mediumEarnings above estimates
Q2-2000: Beat consensus by 31.5% - EPS $-5.8 vs $-8.466 estimate
- mediumEarnings below estimates
Q3-2000: Missed consensus by 12.3% - EPS $-6.3 vs $-5.61 estimate
- mediumEarnings below estimates
Missed consensus by 47.1% - EPS $-4.2 vs $-2.856 estimate
FREE, NO ACCOUNT
Every event on CPMD, as it fires
You are seeing 5 of 8 events recorded on CPMD since 2026-05-31.
The five above landed across 2 days. The other 3 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, CPMD
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
CPMD's 10-Q filed Aug 18, 2026 states:
Accordingly, there is substantial doubt about the Company's ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on CPMD
CPMD against its peers
CPMD's operating margin of -245.8% ranks in the 32nd percentile of 10 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-05-31 and 2026-03-31.
| Metric | CPMD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.4M USD | 2.1M USD | 50 | 10 |
| Revenue YoY | 66.1% | 3.3% | 92 | 5 |
| Gross margin | -153.1% | 35.9% | 5 | 10 |
| Operating margin | -245.8% | -80.1% | 32 | 10 |
| Net margin | -817.2% | -27.9% | 19 | 12 |
| Return on equity | n/a | -42.0% | n/a | 7 |
Peers (14): BUDZ, CBIH, LVRLF, IMCC, SBFM, CVSI, SKYI, NPHC, PRFX, CBDY, APUS, GELS, SNOA, YCBD. Left out: PCYN (period gap), CBDL (no annual filing), NASC (period gap), CANN (period gap), SFWJ (no annual filing), KAYS (period gap), CTTH (period gap), RDHL (period gap), PLSH (period gap), AYRWF (period gap), GREH (no annual filing). Fiscal periods ending between 2025-05-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (CPMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CPMD on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CPMD in the last 180 days.
Upstream: SEC EDGAR filings for CPMD
Kresmion, "CANNAPHARMARX, INC. (CPMD) institutional holdings and SEC filings", data as of 2026-08-18, https://kresmion.com/research/CPMD. Upstream data: SEC EDGAR filings for CPMD.
Link to this data (HTML):
<a href="https://kresmion.com/research/CPMD">CANNAPHARMARX, INC. (CPMD) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CPMD on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CPMD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.